RenovoRx Analyst Price Targets - Benzinga

RenovoRx Inc

RNXTNASDAQ

Trade with Public

Trade with Public

$1.55

-0.01-0.64%

마지막 업데이트: Oct 2, 5:29 AM

$1.53

-0.03-1.92%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 주식 보고서

RenovoRx Analyst Price Targets - Benzinga

RenovoRx Analyst Price Targets

Wall Street analyst price targets and consensus rating for RenovoRx (RNXT).

Price Target Range — 11 Quarters

Analyst Consensus — 4 Analysts

3Buy

1Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$7Upside to Avg. PT+368.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 28, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$14→$15
Jun 1, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$14→$14
Apr 9, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$13→$14
Apr 8, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$3
Feb 17, 2026	Ascendiant Capital	Edward Woo	PT Raise	Buy	$13→$13
Nov 21, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$12→$13
Aug 25, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$12→$12
Jun 5, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$11→$12
May 19, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$3
Apr 28, 2025	Ascendiant Capital	Edward Woo	PT Raise	Buy	$9→$11
Apr 4, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$3
Mar 27, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Initiate	Buy	$3
Dec 10, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$8→$9
Sep 12, 2024	Ascendiant Capital	Edward Woo	PT Raise	Buy	$8→$8
Jun 17, 2024	Ascendiant Capital	Edward Woo	Initiate	Buy	$8
Feb 2, 2024	Alliance Global Partners	Scott Henry	Initiate	Buy	$4
Nov 15, 2023	Maxim Group	Jason McCarthy	Downgrade	Buy→Hold	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $14.5

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $14 to $14.5.

Benzinga Newsdesk

Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know

Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price targets raised/cut, ratings maintained/changed.

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $14

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $13.5 to $14.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $13.5

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $13 to $13.5.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on RenovoRx, Maintains $3 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates RenovoRx (NASDAQ:RNXT) with a Buy and maintains $3 price target.

Benzinga Newsdesk

Micron To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor